Vitamins
746 results
1 - 100
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency- Fortification of staple foods with vitamin A for vitamin A deficiency
- Prophylactic vitamin K for vitamin K deficiency bleeding in neonates
- Vitamins for epilepsy
- Vitamin B12 for cognition
- Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates
- Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children
- Vitamin D for the management of asthma
- Vitamin E for intermittent claudication
- Vitamin E supplementation in pregnancy
- Vitamin C supplementation in pregnancy
- Vitamin K supplementation for cystic fibrosis
- Vitamin A supplementation for postpartum women
- Vitamin D supplementation for cystic fibrosis
- Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health
- Vitamin D and vitamin D analogues for preventing fractures in post‐menopausal women and older men
- Vitamin A for non‐measles pneumonia in children
- Vitamin D for the management of multiple sclerosis
- Vitamin E supplementation in people with cystic fibrosis
- Vitamin C for preventing and treating the common cold
- Vitamin D for the treatment of inflammatory bowel disease
- Vitamin C supplementation for prevention and treatment of pneumonia
- Vitamin D supplementation for sickle cell disease
- Vitamin E for antipsychotic‐induced tardive dyskinesia
- Vitamin B6 for cognition: Cochrane systematic review
- Vitamin D supplementation for women during pregnancy
- Vitamin D supplementation for chronic liver diseases in adults
- Calcium and vitamin D for corticosteroid‐induced osteoporosis
- Vitamin K for the primary prevention of cardiovascular disease
- Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
- Vitamin A supplementation during pregnancy for maternal and newborn outcomes
- Vitamin D for the treatment of chronic painful conditions in adults
- Vitamins C and E for asthma and exercise‐induced bronchoconstriction
- Vitamin E for Alzheimer's dementia and mild cognitive impairment
- Vitamin A for treating measles in children: Cochrane systematic review
- Regimens of vitamin D supplementation for women during pregnancy
- Fortification of rice with vitamins and minerals for addressing micronutrient malnutrition
- Vitamin supplementation for preventing miscarriage: Cochrane systematic review
- Vitamin A supplements for reducing mother‐to‐child HIV transmission
- Vitamin C supplementation for asthma: Cochrane systematic review
- Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
- Vitamin A supplementation during pregnancy: Cochrane systematic review
- Vitamin E supplementation for prevention of morbidity and mortality in preterm infants
- Vitamin D supplementation in pregnancy: Cochrane systematic review
- Vitamin C supplementation for the primary prevention of cardiovascular disease
- Vitamin B supplementation for sickle cell disease
- Vitamin D for the management of chronic obstructive pulmonary disease
- Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
- Vitamin C for preventing and treating pneumonia: Cochrane systematic review
- Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
- Vitamin D compounds for people with chronic kidney disease requiring dialysis
- Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
- Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
- Vitamin C for preventing and treating tetanus: Cochrane systematic review
- Calcium and vitamin D for increasing bone mineral density in premenopausal women
- Vitamin D supplementation for prevention of cancer in adults: Cochrane systematic review
- Combined vitamin B6‐magnesium treatment in autism spectrum disorder
- Vitamin B for treating peripheral neuropathy: Cochrane systematic review
- Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
- Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
- Vitamin D supplementation for the treatment of COVID‐19: a living systematic review
- Vitamin C for asthma and exercise-induced bronchoconstriction: Cochrane systematic review
- Vitamin B and its derivatives for diabetic kidney disease: Cochrane systematic review
- Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases
- Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
- Calcium, vitamin D or recombinant parathyroid hormone for managing post‐thyroidectomy hypoparathyroidism
- Vitamin E for people with non‐alcoholic fatty liver disease
- Vitamin D supplementation for improving bone mineral density in children: Cochrane systematic review
- Vitamin D supplementation for preventing infections in children under five years of age
- Vitamin D supplementation for prevention of mortality in adults: Cochrane systematic review
- Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy: Cochrane systematic review
- Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
- Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
- Vitamin K for improved anticoagulation control in patients receiving warfarin: Cochrane systematic review
- Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract: Cochrane systematic review
- Vitamin D compounds for people with chronic kidney disease not requiring dialysis: Cochrane systematic review
- Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
- Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries
- Topical Vitamin A, or its derivatives, for treating and preventing napkin dermatitis in infants: Cochrane systematic review
- Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
- Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants
- Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
- Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapy
- Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non‐bleeding patients
- Vitamin D for preventing acute respiratory infections in children up to five years of age
- Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
- Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age
- Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age: Cochrane systematic review
- Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes: Cochrane systematic review
- Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
- Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis
- Supplementary vitamin E, selenium, cysteine and riboflavin for preventing kwashiorkor in preschool children in developing countries: Cochrane systematic review
- Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism
- Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin: Cochrane systematic review
- Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis
- Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
- Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review